Deborah Dunsire, Lundbeck president and CEO
February 18, 2022 01:04 PM EST
Pharma
Marketing

Track­ing men­tal health: Lund­beck part­ner­ship de­buts US map­ping dash­board tool

Beth Snyder Bulik

Senior Editor

While the twindem­ic of Covid-19 and in­fluen­za nev­er re­al­ly ma­te­ri­al­ized, a dif­fer­ent dou­ble cri­sis did. Men­tal health is­sues have boomed along­side Covid cas­es dur­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times